Literature DB >> 17679247

A critical analysis of evidence for using sham surgery in Parkinson's disease: implications for public health.

Stephen Polgar1, Joanna Ng.   

Abstract

Sham surgery was introduced as a means for improving the methodological quality of surgical research and evaluation. The development of cellular-based surgical therapies for the treatment of Parkinson's disease provides an opportunity to carefully analyse the alleged methodological benefits of sham surgery. However, detailed analysis of the evidence does not support these hypothesised advantages. In this paper, we argue that sham surgery is a public health concern as vulnerable individuals are exposed to unnecessary and costly surgical procedures that have no benefits for ensuring rigorous health research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17679247     DOI: 10.1111/j.1467-842x.2007.00060.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  3 in total

1.  CD90 Expression on human primary cells and elimination of contaminating fibroblasts from cell cultures.

Authors:  Lynn Kisselbach; Michael Merges; Alexis Bossie; Ann Boyd
Journal:  Cytotechnology       Date:  2009-03-19       Impact factor: 2.058

2.  Strengthening the ethical assessment of placebo-controlled surgical trials: three proposals.

Authors:  Wendy Rogers; Katrina Hutchison; Zoë C Skea; Marion K Campbell
Journal:  BMC Med Ethics       Date:  2014-10-23       Impact factor: 2.652

3.  Potential cellular and regenerative approaches for the treatment of Parkinson's disease.

Authors:  Emma L Lane; Olivia J Handley; Anne E Rosser; Stephen B Dunnett
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.